Market closedNon-fractional
Bio-Techne/TECH
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About Bio-Techne
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.
Ticker
TECH
Sector
Healthcare
Trading on
NASDAQ
Industry
Life Sciences Tools and Services
Headquarters
Minneapolis, United States
Employees
3,050
Website
www.bio-techne.com
Bio-Techne Metrics
BasicAdvanced
$12B
Market cap
62.88
P/E ratio
$1.25
EPS
1.23
Beta
$0.32
Dividend rate
0.41%
Dividend yield
Price and volume
Market cap
$12B
Beta
1.23
Dividend rate
$0.32
Financial strength
Current ratio
4.076
Quick ratio
2.491
Long term debt to equity
23.916
Total debt to equity
24.56
Dividend payout ratio (TTM)
24.82%
Interest coverage (TTM)
14.08%
Management effectiveness
Return on assets (TTM)
5.58%
Return on equity (TTM)
10.40%
Valuation
Price to earnings (TTM)
62.878
Price to revenue (TTM)
10.742
Price to book
6.13
Price to tangible book (TTM)
23.88
Price to free cash flow (TTM)
49.372
Dividend yield (TTM)
0.41%
Growth
Revenue change (TTM)
2.73%
Earnings per share change (TTM)
-25.06%
3-year revenue growth (CAGR)
10.83%
3-year earnings per share growth (CAGR)
2.90%
What the Analysts think about Bio-Techne
Analyst Ratings
Majority rating from 14 analysts.
Bio-Techne Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$303M
11.34%
Net income
$49M
78.83%
Profit margin
16.15%
60.70%
Bio-Techne Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$0.55
$0.41
$0.40
$0.48
-
Expected
$0.55
$0.44
$0.41
$0.45
$0.50
Surprise
0.58%
-5.80%
-3.05%
6.00%
-
Bio-Techne News
AllArticlesVideos
BIO-TECHNE TO HOST CONFERENCE CALL ON AUGUST 7, 2024, TO ANNOUNCE FOURTH QUARTER AND FISCAL 2024 FINANCIAL RESULTS
PRNewsWire·2 weeks ago
BIO-TECHNE TO PRESENT AT UPCOMING INVESTOR CONFERENCES
PRNewsWire·2 months ago
BIO-TECHNE TO HIGHLIGHT MULTIPLE APPLICATIONS OF THE MauriceFlex™ SYSTEM AT THE ANNUAL ASMS CONFERENCE
PRNewsWire·2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Bio-Techne stock?
Bio-Techne (TECH) has a market cap of $12B as of July 27, 2024.
What is the P/E ratio for Bio-Techne stock?
The price to earnings (P/E) ratio for Bio-Techne (TECH) stock is 62.88 as of July 27, 2024.
Does Bio-Techne stock pay dividends?
Yes, the Bio-Techne (TECH) stock pays dividends to shareholders. As of July 27, 2024, the dividend rate is $0.32 and the yield is 0.41%. Bio-Techne has a payout ratio of 24.82% on a trailing twelve-month basis.
When is the next Bio-Techne dividend payment date?
The next Bio-Techne (TECH) dividend payment date is unconfirmed.
What is the beta indicator for Bio-Techne?
Bio-Techne (TECH) has a beta rating of 1.23. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.
Buy or sell Bio-Techne stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.